US$ 22.88
tirzepatide tablets fda approved Compounded Oral – tru2u FDA approval for Zepbound (tirzepatide)
Description
Purity is not one number

Up to 92% of patients on tirzepatide achieved the ADA-recommended A1C target of less than 7%, compared to 81% on semaglutide

But the differences are small enough that they do not matter clinically

Ultimately, the choice between these two medications depends on personal health conditions and goals
